Aquatic Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History

Aquatic Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $655,616 - $1.22 Million	78,800 New	78,800 $686,000
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $16,500 - $22,700	2,000 New	2,000 $19,000
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $157,624 - $190,912	15,200 Added 2533.33%	15,800 $166,000
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $29,700 - $37,290	-3,000 Reduced 83.33%	600 $7,000
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $27,378 - $33,426	-2,700 Reduced 42.86%	3,600 $37,000
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $69,615 - $80,136	6,300 New	6,300 $73,000
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $8,488 - $10,304	-800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $8,688 - $11,160	800 New	800 $9,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $530M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.